Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Jul 1;127(13):2181-2183.
doi: 10.1002/cncr.33495. Epub 2021 Mar 31.

National early access programs and clinical trials: What opportunities for early access to therapeutic innovations for patients with malignant melanoma?

Emmanuelle Kempf  1 , Gérard Zalcman  2 , Céleste Lebbe  3 ; French Society of Cancer Immunotherapy (FTIC)
Affiliations
Free article
Editorial

National early access programs and clinical trials: What opportunities for early access to therapeutic innovations for patients with malignant melanoma?

Emmanuelle Kempf et al. Cancer. .
Free article
No abstract available

Keywords: early access program; innovation; market access; melanoma; trial.

PubMed Disclaimer

Comment on

References

    1. Christen C, Belgodere L, Guillot B, et al. Access to innovation through the national early access program and clinical trials for patients with malignant melanoma. Cancer. 2021;127:2262-2270.
    1. Hodi FS, O’Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363:711-723.doi:10.1056/nejmoa1003466
    1. Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364:2507-2516.doi:10.1056/nejmoa1103782
    1. Jardim DL, Schwaederle M, Hong DS, Kurzrock R. An appraisal of drug development timelines in the era of precision oncology. Oncotarget. 2016;7:53037-53046.doi:10.18632/oncotarget.10588
    1. Thornton Snider J, Seabury S, Tebeka MG, Wu Y, Batt K. The option value of innovative treatments for metastatic melanoma. Forum Heal Econ Policy. 2018;21:/j/hep.2018.21.issue-1/fhep-2016-0014/fhep-2016-0014.xml. doi:10.1515/fhep-2016-0014

LinkOut - more resources